Atlas Trials

Study to Evaluate the Efficacy and Safety of Elafibranor in Patients With Primary Biliary Cholangitis (PBC) and Inadequate Response to Ursodeoxycholic Acid

Clinical trial NCT03124108 · COMPLETED

Trial details

NCT number
NCT03124108
Sponsor
Genfit
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Primary Biliary Cholangitis (PBC)
Start date
2017-04-05
Primary completion
2018-10-31
Enrollment
45

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.